Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC, C4591001 Clinical Trial Group

Open source

DOI: 10.1056/nejmoa2034577
Published: 2020 Dec 31
Container: The New England journal of medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2034577,
  title = {Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.},
  author = {Polack FP and Thomas SJ and Kitchin N and Absalon J and Gurtman A and Lockhart S and Perez JL and Pérez Marc G and Moreira ED and Zerbini C and Bailey R and Swanson KA and Roychoudhury S and Koury K and Li P and Kalina WV and Cooper D and Frenck RW Jr and Hammitt LL and Türeci Ö and Nell H and Schaefer A and Ünal S and Tresnan DB and Mather S and Dormitzer PR and Şahin U and Jansen KU and Gruber WC and C4591001 Clinical Trial Group},
  year = {2020},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2034577},
  url = {https://doi.org/10.1056/nejmoa2034577}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
AU  - Polack FP
AU  - Thomas SJ
AU  - Kitchin N
AU  - Absalon J
AU  - Gurtman A
AU  - Lockhart S
AU  - Perez JL
AU  - Pérez Marc G
AU  - Moreira ED
AU  - Zerbini C
AU  - Bailey R
AU  - Swanson KA
AU  - Roychoudhury S
AU  - Koury K
AU  - Li P
AU  - Kalina WV
AU  - Cooper D
AU  - Frenck RW Jr
AU  - Hammitt LL
AU  - Türeci Ö
AU  - Nell H
AU  - Schaefer A
AU  - Ünal S
AU  - Tresnan DB
AU  - Mather S
AU  - Dormitzer PR
AU  - Şahin U
AU  - Jansen KU
AU  - Gruber WC
AU  - C4591001 Clinical Trial Group
PY  - 2020
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2034577
UR  - https://doi.org/10.1056/nejmoa2034577
ER  -

APA

FP, P., SJ, T., N, K., J, A., A, G., S, L., JL, P., G, P. M., ED, M., C, Z., R, B., KA, S., S, R., K, K., P, L., WV, K., D, C., Jr, F. R., LL, H., Ö, T., H, N., A, S., S, Ü., DB, T., S, M., PR, D., U, Ş., KU, J., WC, G., & Group, C. C. T. (2020). Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2034577

Source records

pubmed · retrieved 2026-09-25T00:35:29.491Z